anonymous
Guest
anonymous
Guest
David Alderman and his team currently maintain offices in 27 countries around the globe. For a pharmaceutical company, this is tremendously advantageous, as it allows me to gain valuable insights into distant markets such as Zambia, Sri Lanka, and Papua New Guinea. The last time we spoke, he wasn’t entirely certain whether the figure was 27 or 29, as they’re constantly opening and closing sites worldwide. Moreover, his colleagues—particularly Mark Powzaniuk—are exceptionally knowledgeable and can tackle virtually any question you throw at them.